TNFSF10 and neoplasm: Thus, number of studies have been looking for the novel formulations of TRAIL (extensively reviewed by de Miguel et al. [55]) or TRAIL-based co-therapies with agents sensitizing tumor cells to its activity [30,31,32,36,37,56,57,58].